NEW YORK, March 12 - Edward Dratz , a chemistry professor at Montana State University , will journey eastward on a proteomics-themed sabbatical, traveling to the Medical College of Wisconsin , the University of Wisconsin and to the Mayo Clinic , to work with mass spectrometers, the Montana State University News service said today in a report on the school's sabbatical approvals.
Dratz, whose lab studies membrane receptor, amplifier, and adhesion proteins, received his PhD from the
Bertrand Damour has been promoted to CEO of GeneProt , the company said March 11.
Damour was previously serving as co-chair of GeneProt's operating committee since GeneProt CEO and founder Cedric Loiret-Bernal left the Geneva-based proteomics company in April. Prior to that, he served as CFO.
Damour holds an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University , as well as a master's of engineering degree in nuclear physics from the Institut des Sciences de la Matière et du Rayonnement in France, and a master's degree in accounting and business administration from the Institut d'Administration des Entreprises .
Brad Popovich has been named the chairman of Tm Bioscience 's scientific advisory board, and has also been appointed to the company's board of directors, the company said March 11. Tm, of
Popovich is vice president of operations at Xenon Genetics of Burnaby, British Columbia. Previously, he directed the DNA diagnostic laboratory and clinical genetic laboratories at
Cole is deputy chief of the department of clinical pathology at the Sunnybrook and Women's
Eugene Myers has been appointed to the scientific advisory board of 454 Life Sciences , the Curagen instrumentation spinout said March 11.
Myers is currently a professor of computer science at the
Confirmant has launched a scientific advisory board and has appointed Graham Cameron , Duncan Campbell , and Michael Liebman as members, the company said March 10.
Cameron is associate director of the European Bioinformatics Institute in
The Abingdon UK company, a joint venture of Oxford Glycosciences and Marconi , markets a "protein atlas of the human genome."
John W. Kozarich , CEO and CSO of ActivX Biosciences , has been appointed to the board of directors of Ligand Pharmaceuticals in
In addition to heading up La Jolla-based ActivX, which studies disease mechanisms by analyzing protein activity, Kozarich also is a biotechnology professor at Scripps Research Institute . He has previously served as vice president at Merck Research Laboratories , and held faculty positions at Yale and the